Although KRAS gene mutation is rare in human gliomas, studies have shown that KRAS-G12C can drive the formation of malignant gliomas in mice and KRAS-G12D also plays a role in the progression of astrocytoma to high-grade gliomas 17, 18. This evidence concerns the gene KRAS and malignant glioma.